comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 21:47:50 - browse：1316

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Studies point to risks of excluding people with obesity from drug trials

WSS

The explosion of genetic testing requires a new approach

Flagship, Pfizer team up in deal worth up to $7 billion

STAT Summit: How a Chicago ER doctor tackles gun violence

STAT Summit: Biotech founders on deal

Flagship, Pfizer team up in deal worth up to $7 billion

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

hotspot

comprehensive

Wikipedia

Supreme Court strikes down use of affirmative action

BridgeBio heart drug succeeds in pivotal study

Medicare details structure of new drug price negotiation program

First Opinion Podcast: Long Covid needs a new approach

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The explosion of genetic testing requires a new approach

23andMe had bad news about my health. I wish a person had delivered it

Eli Lilly expects to double planned employment in Boston center

Sports medicine is finally prioritizing gender equality

FDA struggles to regulate food additives, sometimes for decades

focus

Twill hunts for pharma partner to market its depression app

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

STAT Readout Newsletter: Today's biggest biotech updates

Medicare reduced heart disease by changing how it pays doctors

ER docs worry over extreme heat as a 'mass casualty event'

Study: Hearing aids may slow cognitive decline in those at risk

focus

hotspot

leisure time

Wikipedia